Scpharmaceuticals Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Scpharmaceuticals Stock Summary

Scpharmaceuticals competes with Milestone Pharmaceuticals, Oncolytics Biotech, Seres Therapeutics, DiaMedica Therapeutics, and Lyra Therapeutics. scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts. SC Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people.

Scpharmaceuticals Key Financial Ratios

Scpharmaceuticals Key Balance Sheet Accounts

Scpharmaceuticals Key Income Statement Accounts

Scpharmaceuticals Key Cash Accounts

Scpharmaceuticals Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Scpharmaceuticals's current stock value. Our valuation model uses many indicators to compare Scpharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Scpharmaceuticals competition to find correlations between indicators driving Scpharmaceuticals's intrinsic value. More Info.Scpharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . As of now, Scpharmaceuticals' Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Scpharmaceuticals' earnings, one of the primary drivers of an investment's value.

Scpharmaceuticals Systematic Risk

Today, most investors in Scpharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Scpharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Scpharmaceuticals growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Scpharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Scpharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Scpharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Scpharmaceuticals Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Scpharmaceuticals's daily price indicators and compare them against related drivers.

When running Scpharmaceuticals' price analysis, check to measure Scpharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scpharmaceuticals is operating at the current time. Most of Scpharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Scpharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scpharmaceuticals' price. Additionally, you may evaluate how the addition of Scpharmaceuticals to your portfolios can decrease your overall portfolio volatility.